Full Text View
Tabular View
Study Results
Related Studies
Evaluating the Cost-effectiveness, Efficacy, Safety and Tolerance of Mepilex® Ag Versus Silvadene®
This study has been completed.
Study NCT00742183   Information provided by Molnlycke Health Care AB

First Received on August 19, 2008.   Last Updated on October 11, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Second Degree Burn
Additional conditions recognized in this trial
Burns
More general conditions related to this trial
Wounds and Injuries
Interventions listed in this trial
Mepilex
Silvadene
Additional drug interventions recognized in this trial
Silver Sulfadiazine
More general drug interventions related to this trial
Anti-Infective Agents
Anti-Infective Agents, Local
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Molnlycke Health Care AB


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services